SNBIF (SanBio Co) Shares Outstanding (EOP): 78.03 Mil (As of Jan. 2026)


SNBIF SanBio Co Ltd SNBIF
22 GF Score
Price $16.45
! 1 Warning Sign
View Full Analysis

What is SanBio Co Shares Outstanding (EOP)?

SanBio Co SNBIF 22 Shares Outstanding (EOP) is 78.03 Mil as of Jan. 2026. GuruFocus rates SNBIF with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. SanBio Co's shares outstanding for the quarter that ended in Jan. 2026 was 78.03 Mil.

SanBio Co's quarterly shares outstanding increased from Oct. 2025 (72.03 Mil) to Jan. 2026 (78.03 Mil). It means SanBio Co issued new shares from Oct. 2025 to Jan. 2026 .

SanBio Co's annual shares outstanding increased from Jan. 2025 (70.93 Mil) to Jan. 2026 (78.03 Mil). It means SanBio Co issued new shares from Jan. 2025 to Jan. 2026 .


SanBio Co  (OTCPK:SNBIF) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


SanBio Co Shares Outstanding (EOP) Related Terms


SanBio Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for SanBio Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SanBio Co Shares Outstanding (EOP) Chart

SanBio Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.79 64.08 67.93 70.93 78.03

SanBio Co Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.02 72.03 72.03 78.03 78.04

SNBIF vs VRTX, REGN, ALNY: Shares Outstanding (EOP) Comparison

For the Biotechnology subindustry, SanBio Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co Shares Outstanding (EOP) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where SanBio Co's Shares Outstanding (EOP) falls into.


SNBIF
22GF Score
SanBio Co Ltd SNBIF
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SanBio Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 78.03 Mil mean?
SanBio Co (SNBIF) has a Shares Outstanding (EOP) of 78.03 Mil as of Jan. 2026. The total shares a company has outstanding, at period-end. View historical data on SanBio Co and its competitors.
Is SanBio Co's Shares Outstanding (EOP) too high?
SanBio Co's current Shares Outstanding (EOP) is 78.03 Mil. Overall, SanBio Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does SanBio Co's Shares Outstanding (EOP) compare to VRTX and REGN?
SanBio Co's Shares Outstanding (EOP) of 78.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Biotechnology company?
A good Shares Outstanding (EOP) depends on the Biotechnology industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on SanBio Co and its competitors. SanBio Co's current Shares Outstanding (EOP) is 78.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SanBio Co stock overvalued right now?
SanBio Co (SNBIF) has a current Shares Outstanding (EOP) of 78.03 Mil. The current Shares Outstanding (EOP) is 78.03 Mil. SanBio Co's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For SanBio Co (SNBIF), the current Shares Outstanding (EOP) is 78.03 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SanBio Co Business Description

Other Exchanges 4592:Japan
Address 8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.
22GF Score

Get the complete analysis for SNBIF

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.45
Price